Eagle Health Investments LP - Q1 2023 holdings

$514 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
SGEN  SEAGEN INC$35,412,408
+57.6%
174,9020.0%6.89%
+33.0%
UTHR  UNITED THERAPEUTICS CORP DEL$29,392,062
-19.5%
131,2380.0%5.72%
-32.0%
INSP  INSPIRE MED SYS INC$23,768,170
-7.1%
101,5430.0%4.63%
-21.6%
FDMT  4D MOLECULAR THERAPEUTICS IN$7,527,690
-22.6%
437,9110.0%1.46%
-34.7%
AGIO  AGIOS PHARMACEUTICALS INC$6,147,461
-18.2%
267,6300.0%1.20%
-31.0%
AMWL  AMERICAN WELL CORPcl a$3,292,292
-16.6%
1,395,0390.0%0.64%
-29.6%
CMAX  CAREMAX INC$1,908,396
-26.8%
714,7550.0%0.37%
-38.2%
OLK  OLINK HLDG ABsponsored ads$901,200
-11.2%
40,0000.0%0.18%
-25.2%
BEAM  BEAM THERAPEUTICS INC$884,918
-21.7%
28,9000.0%0.17%
-34.1%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$499,845
-28.1%
23,5000.0%0.10%
-39.4%
LYEL  LYELL IMMUNOPHARMA INC$236,000
-32.0%
100,0000.0%0.05%
-42.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings